By Alexander Gaffney, RF News Editor
The European Medicines Agency (EMA) has released a new general guidance document on the development of medicinal products intended to treat asthma, a condition that restricts a patient’s airways and can be fatal if improperly treated.
EMA Releases Draft Guidance on Development of Asthma Medications.